These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25766669)
1. Outcomes following implementation of symptom triggered diagnostic testing for ovarian cancer. Rai N; Nevin J; Downey G; Abedin P; Balogun M; Kehoe S; Sundar S Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():64-9. PubMed ID: 25766669 [TBL] [Abstract][Full Text] [Related]
2. Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer. Sundar S; Rick C; Dowling F; Au P; Snell K; Rai N; Champaneria R; Stobart H; Neal R; Davenport C; Mallett S; Sutton A; Kehoe S; Timmerman D; Bourne T; Van Calster B; Gentry-Maharaj A; Menon U; Deeks J; BMJ Open; 2016 Aug; 6(8):e010333. PubMed ID: 27507231 [TBL] [Abstract][Full Text] [Related]
3. Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records. Lim AW; Mesher D; Sasieni P BMC Fam Pract; 2014 Dec; 15():200. PubMed ID: 25496012 [TBL] [Abstract][Full Text] [Related]
4. Urgent GP referrals for suspected lung, colorectal, prostate and ovarian cancer. Allgar VL; Neal RD; Ali N; Leese B; Heywood P; Proctor G; Evans J Br J Gen Pract; 2006 May; 56(526):355-62. PubMed ID: 16638251 [TBL] [Abstract][Full Text] [Related]
5. Two week waits: What are we waiting for? Abdelraheim AR; Khairy M; Mohammed M; Lawrence A Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():112-117. PubMed ID: 28609712 [TBL] [Abstract][Full Text] [Related]
6. Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Neal RD; Allgar VL; Ali N; Leese B; Heywood P; Proctor G; Evans J Br J Gen Pract; 2007 Mar; 57(536):212-9. PubMed ID: 17359608 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of urgent referrals for suspected gynaecological malignancies. Burbos N; Musonda P; Rufford B Arch Gynecol Obstet; 2011 Dec; 284(6):1495-500. PubMed ID: 21331542 [TBL] [Abstract][Full Text] [Related]
8. One-stop clinic for patients with suspected ovarian cancer: results from a retrospective outcome study of the referral pathway. Ashmore AA; Gnanachandran C; Luqman I; Horrocks K BMC Womens Health; 2021 Dec; 21(1):429. PubMed ID: 34961545 [TBL] [Abstract][Full Text] [Related]
9. Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care. Barrett J; Sharp DJ; Stapley S; Stabb C; Hamilton W BJOG; 2010 Apr; 117(5):610-4. PubMed ID: 20121830 [TBL] [Abstract][Full Text] [Related]
10. Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study. Kwong FL; Kristunas C; Davenport C; Aggarwal R; Deeks J; Mallett S; Kehoe S; Timmerman D; Bourne T; Stobart H; Neal R; Menon U; Gentry-Maharaj A; Sturdy L; Ottridge R; Sundar S; BJOG; 2024 Sep; 131(10):1400-1410. PubMed ID: 38556698 [TBL] [Abstract][Full Text] [Related]
11. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ; J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of women referred to the two-week wait gynaecology clinic with suspected ovarian cancer. Jeffery HE; Gillespie AM; Macdonald M Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():145-149. PubMed ID: 34653919 [TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study. Baun ML; Jensen H; Falborg AZ; Heje HN; Petersen LK; Vedsted P Fam Pract; 2019 Nov; 36(6):751-757. PubMed ID: 31046091 [TBL] [Abstract][Full Text] [Related]
14. Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer. Boac BM; Xiong Y; Apte SM; Wenham RM; Shahzad MM; Munroe DG; Lancaster JM; Chon HS Am J Obstet Gynecol; 2018 Apr; 218(4):436.e1-436.e7. PubMed ID: 29353030 [TBL] [Abstract][Full Text] [Related]
15. Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care. Creak A Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e87-e92. PubMed ID: 31635979 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of abnormal blood tests for detecting cancer in primary care patients with nonspecific abdominal symptoms: A population-based cohort study of 477,870 patients in England. Rafiq M; Renzi C; White B; Zakkak N; Nicholson B; Lyratzopoulos G; Barclay M PLoS Med; 2024 Jul; 21(7):e1004426. PubMed ID: 39078806 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of screening for ovarian cancer using symptoms as selection criteria. Rufford BD; Jacobs IJ; Menon U BJOG; 2007 Jan; 114(1):59-64. PubMed ID: 17233861 [TBL] [Abstract][Full Text] [Related]
18. Primary-to-secondary care referral experience of suspected colorectal malignancy in young adults. Patel K; Doulias T; Hoad T; Lee C; Alberts JC Ann R Coll Surg Engl; 2016 May; 98(5):308-13. PubMed ID: 27023637 [TBL] [Abstract][Full Text] [Related]
19. Value of symptom-triggered diagnostic evaluation for ovarian cancer. Andersen MR; Lowe KA; Goff BA Obstet Gynecol; 2014 Jan; 123(1):73-79. PubMed ID: 24463666 [TBL] [Abstract][Full Text] [Related]
20. Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines. Crawford SM; Evans C Fam Pract; 2018 Mar; 35(2):199-202. PubMed ID: 29029123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]